Faculty Opinions recommendation of Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission.

Author(s):  
Alan Landay
2011 ◽  
Vol 3 (112) ◽  
pp. 112re4-112re4 ◽  
Author(s):  
K. B. Patterson ◽  
H. A. Prince ◽  
E. Kraft ◽  
A. J. Jenkins ◽  
N. J. Shaheen ◽  
...  

2015 ◽  
Vol 90 (6) ◽  
pp. 2928-2937 ◽  
Author(s):  
Ai-Ping Jiang ◽  
Jin-Feng Jiang ◽  
Ji-Fu Wei ◽  
Ming-Gao Guo ◽  
Yan Qin ◽  
...  

ABSTRACTThe gastrointestinal mucosa is the primary site where human immunodeficiency virus type 1 (HIV-1) invades, amplifies, and becomes persistently established, and cell-to-cell transmission of HIV-1 plays a pivotal role in mucosal viral dissemination. Mast cells are widely distributed in the gastrointestinal tract and are early targets for invasive pathogens, and they have been shown to have increased density in the genital mucosa in HIV-infected women. Intestinal mast cells express numerous pathogen-associated molecular patterns (PAMPs) and have been shown to combat various viral, parasitic, and bacterial infections. However, the role of mast cells in HIV-1 infection is poorly defined. In this study, we investigated their potential contributions to HIV-1 transmission. Mast cells isolated from gut mucosal tissues were found to express a variety of HIV-1 attachment factors (HAFs), such as DC-SIGN, heparan sulfate proteoglycan (HSPG), and α4β7 integrin, which mediate capture of HIV-1 on the cell surface. Intriguingly, following coculture with CD4+T cells, mast cell surface-bound viruses were efficiently transferred to target T cells. Prior blocking with anti-HAF antibody or mannan before coculture impaired viraltrans-infection. Cell-cell conjunctions formed between mast cells and T cells, to which viral particles were recruited, and these were required for efficient cell-to-cell HIV-1 transmission. Our results reveal a potential function of gut mucosal mast cells in HIV-1 dissemination in tissues. Strategies aimed at preventing viral capture and transfer mediated by mast cells could be beneficial in combating primary HIV-1 infection.IMPORTANCEIn this study, we demonstrate the role of human mast cells isolated from mucosal tissues in mediating HIV-1trans-infection of CD4+T cells. This finding facilitates our understanding of HIV-1 mucosal infection and will benefit the development of strategies to combat primary HIV-1 dissemination.


AIDS ◽  
2017 ◽  
Vol 31 (14) ◽  
pp. 1935-1943 ◽  
Author(s):  
Hiroyuki Gatanaga ◽  
Zabrina L. Brumme ◽  
Emily Adland ◽  
Gustavo Reyes-Terán ◽  
Santiago Avila-Rios ◽  
...  

AIDS ◽  
2014 ◽  
Vol 28 (10) ◽  
pp. 1539-1541 ◽  
Author(s):  
Sami H. Al-Hajjar ◽  
Husn H. Frayha ◽  
Mohammad Al-Hazmi ◽  
Reem Batawi ◽  
Kenneth McIntosh ◽  
...  

2010 ◽  
Vol 54 (7) ◽  
pp. 2994-3001 ◽  
Author(s):  
Luca Vangelista ◽  
Massimiliano Secchi ◽  
Xiaowen Liu ◽  
Angela Bachi ◽  
Letong Jia ◽  
...  

ABSTRACT The development of effective microbicides for the prevention of HIV-1 sexual transmission represents a primary goal for the control of AIDS epidemics worldwide. A promising strategy is the use of bacteria belonging to the vaginal microbiota as live microbicides for the topical production of HIV-1 inhibitors. We have engineered a human vaginal isolate of Lactobacillus jensenii to secrete the anti-HIV-1 chemokine RANTES, as well as C1C5 RANTES, a mutated analogue that acts as a CCR5 antagonist and therefore is devoid of proinflammatory activity. Full-length wild-type RANTES and C1C5 RANTES secreted by L. jensenii were purified to homogeneity and shown to adopt a correctly folded conformation. Both RANTES variants were shown to inhibit HIV-1 infection in CD4+ T cells and macrophages, displaying strong activity against HIV-1 isolates of different genetic subtypes. This work provides proof of principle for the use of L. jensenii-produced C1C5 RANTES to block HIV-1 infection of CD4+ T cells and macrophages, setting the basis for the development of a live anti-HIV-1 microbicide targeting CCR5 in an antagonistic manner.


Vaccines ◽  
2020 ◽  
Vol 8 (1) ◽  
pp. 44
Author(s):  
Ursula Dietrich

Despite the great success of antiretroviral therapy, both in the treatment and prevention of HIV-1 infection, a vaccine is still urgently needed to end the epidemic [...]


AIDS ◽  
2015 ◽  
Vol 29 (12) ◽  
pp. 1467-1471 ◽  
Author(s):  
Scott C. Olson ◽  
Nicole Ngo-Giang-Huong ◽  
Ingrid Beck ◽  
Wenjie Deng ◽  
Paula Britto ◽  
...  

2016 ◽  
Vol 375 (9) ◽  
pp. 830-839 ◽  
Author(s):  
Myron S. Cohen ◽  
Ying Q. Chen ◽  
Marybeth McCauley ◽  
Theresa Gamble ◽  
Mina C. Hosseinipour ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document